Evidence map›Paper›PMID 35631606›Full record

ReviewPharmaceutics2022

Antibiotics-Free Compounds for Chronic Wound Healing.

David O Oluwole, Lucy Coleman, William Buchanan, Tao Chen, Roberto M La Ragione, Lian X Liu

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07488247 (Single-Centre, Open-labeled, Randomized, Phase IIb and Phase III Clinical Studies to Evaluate the Safety, Tolerability, and Efficacy of Chlorin E6), which is not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07488247 phase3recruitingnot on this mapstarted 2026, after this paper: background citation

Single-Centre, Open-labeled, Randomized, Phase IIb and Phase III Clinical Studies to Evaluate the Safety, Tolerability, and Efficacy of Chlorin E6 (Gel Formation) as a Photosensitizing Agent for the Management of Diabetic Foot Ulcers With Photodynamic Therapy.

TypeinterventionalSponsorUnited Medical and Dental CollegeRan2026 to 2027Enrolled300ConditionsDiabetic Foot Ulcer (DFU)ArmsChlorin E6 Gel
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Curcumin-Functionalized Graphene Oxide Strongly PreventsPharmaceuticals (Basel, Switzerland) · 2023
    Article
  13. Metal-Phenolic Networks for Chronic Wounds Therapy.International journal of nanomedicine · 2023
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

David O OluwoleChemical and Process Engineering Department, Faculty of Engineering and Physical Science, University of Surrey, Guildford GU2 7XH, UK.ORCID 0000-0002-3018-327X
Lucy ColemanChemical and Process Engineering Department, Faculty of Engineering and Physical Science, University of Surrey, Guildford GU2 7XH, UK.
William BuchananPhytoceutical Limited, Midhurst, West Sussex GU29 9DJ, UK.
Tao ChenChemical and Process Engineering Department, Faculty of Engineering and Physical Science, University of Surrey, Guildford GU2 7XH, UK.ORCID 0000-0002-3941-1603
Roberto M La RagioneSchool of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK.
Lian X LiuChemical and Process Engineering Department, Faculty of Engineering and Physical Science, University of Surrey, Guildford GU2 7XH, UK.ORCID 0000-0003-2230-2934
University of Surrey · GB

Funding

Medical Research Council MC_PC_19052
6 · The paper itself

Abstract

The rapid rise in the health burden associated with chronic wounds is of great concern to policymakers, academia, and industry. This could be attributed to the devastating implications of this condition, and specifically, chronic wounds which have been linked to invasive microbial infections affecting patients' quality of life. Unfortunately, antibiotics are not always helpful due to their poor penetration of bacterial biofilms and the emergence of antimicrobial resistance. Hence, there is an urgent need to explore antibiotics-free compounds/formulations with proven or potential antimicrobial, anti-inflammatory, antioxidant, and wound healing efficacy. The mechanism of antibiotics-free compounds is thought to include the disruption of the bacteria cell structure, preventing cell division, membrane porins, motility, and the formation of a biofilm. Furthermore, some of these compounds foster tissue regeneration by modulating growth factor expression. In this review article, the focus is placed on a number of non-antibiotic compounds possessing some of the aforementioned pharmacological and physiological activities. Specific interest is given to

Indexed as

antibiotics-freeanti-inflammatoryantimicrobialantimicrobial resistancechronic wounds

Identifiers

PMID35631606
PMCPMC9143489
OpenAlexW4229441379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.